{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T23:14:17Z","timestamp":1769987657772,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s11899-017-0416-8","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T07:08:58Z","timestamp":1508828938000},"page":"513-521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Models of Prognostication in Chronic Myelomonocytic Leukemia"],"prefix":"10.1007","volume":"12","author":[{"given":"Francesco","family":"Onida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"issue":"1","key":"416_CR1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood-2008-01-134858","volume":"112","author":"DE Rollison","year":"2008","unstructured":"Rollison DE, Howlader N, Smith MT, Strom SS, Merritt WD, Ries LA, et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood. 2008;112(1):45\u201352.","journal-title":"Blood"},{"key":"416_CR2","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):blood-2016-03-643544. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27069254 . This article includes the very last WHO diagnostic and subclassification criteria for CMML.","DOI":"10.1182\/blood-2016-03-643544"},{"issue":"4","key":"416_CR3","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1365-2141.1994.tb06734.x","volume":"87","author":"JM Bennett","year":"1994","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick H, et al. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol. 1994;87(4):746\u201354. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7986717","journal-title":"Br J Haematol"},{"key":"416_CR4","doi-asserted-by":"crossref","unstructured":"Onida F, Beran M. Diagnosis and management of chronic myelomonocytic leukemia. 3, Current Hematologic Malignancy Reports. 2008. p. 31\u20136.","DOI":"10.1007\/s11899-008-0006-x"},{"issue":"9","key":"416_CR5","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3324\/haematol.2013.084020","volume":"98","author":"F Onida","year":"2013","unstructured":"Onida F, Barosi G, Leone G, Malcovati L, Morra E, Santini V, et al. Management recommendations for chronic myelomonocytic leukemia: consensus statements from the SIE, SIES, GITMO groups. Haematologica. 2013;98(9):1344\u201352.","journal-title":"Haematologica"},{"issue":"2","key":"416_CR6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51(2):189\u201399.","journal-title":"Br J Haematol"},{"issue":"3","key":"416_CR7","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1182\/blood.V63.3.634.634","volume":"63","author":"P Solal-Celigny","year":"1984","unstructured":"Solal-Celigny P, Desaint B, Herrera A, Chastang C, Amar M, Vroclans M, et al. Chronic myelomonocytic leukemia according to FAB classification: analysis of 35 cases. Blood. 1984;63(3):634\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6582939","journal-title":"Blood"},{"issue":"3","key":"416_CR8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2141.1985.tb07329.x","volume":"59","author":"GJ Mufti","year":"1985","unstructured":"Mufti GJ, Stevens JR, Oscier DG, Hamblin TJ, Machin D. Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol. 1985;59(3):425\u201333.","journal-title":"Br J Haematol"},{"issue":"2","key":"416_CR9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/hon.2900030206","volume":"3","author":"EP Alessandrino","year":"1985","unstructured":"Alessandrino EP, Orlandi E, Brusamolino E, Lazzarino M, Morra E, Castagnola C, et al. Chronic myelomonocytic leukemia: clinical features, cytogenetics, and prognosis in 30 consecutive cases. Hematol Oncol. 1985;3(2):147\u201355.","journal-title":"Hematol Oncol"},{"issue":"1","key":"416_CR10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.1987.tb06142.x","volume":"65","author":"P Fenaux","year":"1987","unstructured":"Fenaux P, Jouet JP, Zandecki M, Lai JL, Simon M, Pollet JP, et al. Chronic and subacute myelomonocytic leukaemia in the adult: a report of 60 cases with special reference to prognostic factors. Br J Haematol. 1987;65(1):101\u20136.","journal-title":"Br J Haematol"},{"issue":"1","key":"416_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/bjc.1987.154","volume":"56","author":"J Stark","year":"1987","unstructured":"Stark J, Head C, Roberts BE, Scott CS. AN. T. Prognostic factors and survival in chronic myelomonocytic leukaemia (CMML). Br J Cancer. 1987;56(1):59\u201363.","journal-title":"Br J Cancer"},{"issue":"2","key":"416_CR12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0609.1988.tb00880.x","volume":"41","author":"M Weide van der","year":"1988","unstructured":"van der Weide M, Sizoo W, Nauta JJ, Krefft J, Langenhuijsen MM. Myelodysplastic syndromes: analysis of clinical and prognostic features in 96 patients. Eur J Haematol. 1988;41(2):115\u201322. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3165865","journal-title":"Eur J Haematol"},{"issue":"3","key":"416_CR13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ajh.2830270303","volume":"27","author":"S Garc\u00eda","year":"1988","unstructured":"Garc\u00eda S, Sanz MA, Amigo V, Colomina P, Carrera MD, Lorenzo JI, et al. Prognostic factors in chronic myelodysplastic syndromes: a multivariate analysis in 107 cases. Am J Hematol. 1988;27(3):163\u20138.","journal-title":"Am J Hematol"},{"issue":"9","key":"416_CR14","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1200\/JCO.1988.6.9.1417","volume":"6","author":"P Fenaux","year":"1988","unstructured":"Fenaux P, Beuscart R, Lai JL, Jouet JP, Bauters F. Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases. J Clin Oncol. 1988;6(9):1417\u201324.","journal-title":"J Clin Oncol"},{"issue":"1","key":"416_CR15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2141.1988.tb04173.x","volume":"68","author":"A Worsley","year":"1988","unstructured":"Worsley A, Oscier DG, Stevens J, Darlow S, Figes A, Mufti GJ, et al. Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival. Br J Haematol. 1988;68(1):17\u201321.","journal-title":"Br J Haematol"},{"issue":"1","key":"416_CR16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood.V74.1.395.395","volume":"74","author":"GF Sanz","year":"1989","unstructured":"Sanz GF, Sanz MA, Vallesp\u00ed T, Ca\u00f1izo MC, Torrabadella M, Garc\u00eda S, et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood. 1989;74(1):395\u2013408. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2752119","journal-title":"Blood"},{"issue":"5","key":"416_CR17","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1600-0609.1989.tb01472.x","volume":"42","author":"MC Ca\u00f1izo del","year":"1989","unstructured":"del Ca\u00f1izo MC, Sanz G, San Miguel JF, Vallespi T, Irriguible D, Torrabadella M, et al. Chronic myelomonocytic leukemia\u2014clinicobiological characteristics: a multivariate analysis in a series of 70 cases. Eur J Haematol. 1989;42(5):466\u201373. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2731594","journal-title":"Eur J Haematol"},{"issue":"10","key":"416_CR18","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0025-6196(12)61287-7","volume":"64","author":"A Tefferi","year":"1989","unstructured":"Tefferi A, Hoagland HC, Therneau TM, Pierre RV. Chronic myelomonocytic leukemia: natural history and prognostic determinants. Mayo Clin Proc. 1989;64(10):1246\u201354. Available from: http:\/\/www.embase.com\/search\/results?subaction=viewrecord&from=export&id=L20005760%5Cnhttp:\/\/sfx.ub.rug.nl:9003\/sfx_local?sid=EMBASE&issn=00256196&id=doi:&atitle=Chronic+myelomonocytic+leukemia:+Natural+history+and+prognostic+determinants&stitle=MAYO+CLIN","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"416_CR19","first-page":"766","volume":"4","author":"AM Storniolo","year":"1990","unstructured":"Storniolo AM, Moloney WC, Rosenthal DS, Cox C, Bennett JM. Chronic myelomonocytic leukemia. Leukemia. 1990;4(11):766\u201370.","journal-title":"Leukemia"},{"issue":"1","key":"416_CR20","first-page":"52","volume":"6","author":"C Aul","year":"1992","unstructured":"Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia. 1992;6(1):52\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1736014","journal-title":"Leukemia"},{"issue":"4","key":"416_CR21","first-page":"324","volume":"81","author":"L Catalano","year":"1996","unstructured":"Catalano L, Improta S, de Laurentiis M, Molica S, Majolino I, Musto P, et al. Prognosis of chronic myelomonocytic leukemia. Haematologica. 1996;81(4):324\u20139.","journal-title":"Haematologica"},{"issue":"9","key":"416_CR22","first-page":"1315","volume":"7","author":"P Morel","year":"1993","unstructured":"Morel P, Hebbar M, Lai JL, Duhamel A, Preudhomme C, Wattel E, et al. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia. 1993;7(9):1315\u201323. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8371581","journal-title":"Leukemia"},{"issue":"7","key":"416_CR23","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/1042819042000207271","volume":"45","author":"U Germing","year":"2004","unstructured":"Germing U, K\u00fcndgen A, Gattermann N. Risk assessment in chronic myelomonocytic leukemia (CMML). Leuk Lymphoma. 2004;45(7):1311\u20138.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"416_CR24","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","volume":"89","author":"P Greenberg","year":"1997","unstructured":"Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89(6):2079\u201388. Available from: http:\/\/www.bloodjournal.org\/content\/89\/6\/2079.abstract","journal-title":"Blood"},{"issue":"6","key":"416_CR25","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/cncr.23697","volume":"113","author":"H Kantarjian","year":"2008","unstructured":"Kantarjian H, O\u2019Brien S, Ravandi F, Cortes J, Shan J, Bennett JM, et al. Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System. Cancer. 2008;113(6):1351\u201361.","journal-title":"Cancer"},{"issue":"8","key":"416_CR26","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2011.35.6394","volume":"30","author":"J Schanz","year":"2012","unstructured":"Schanz J, T\u00fcchler H, Sol\u00e9 F, Mallo M, Lu\u00f1o E, Cervera J, et al. New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. J Clin Oncol. 2012;30(8):820\u20139.","journal-title":"J Clin Oncol"},{"issue":"30","key":"416_CR27","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1200\/JCO.2005.01.7038","volume":"23","author":"L Malcovati","year":"2005","unstructured":"Malcovati L, Della Porta MG, Pascutto C, Invernizzi R, Boni M, Travaglino E, et al. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. J Clin Oncol. 2005;23(30):7594\u2013603.","journal-title":"J Clin Oncol"},{"issue":"23","key":"416_CR28","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2006.08.5696","volume":"25","author":"L Malcovati","year":"2007","unstructured":"Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, Invernizzi R, et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol. 2007;25(23):3503\u201310.","journal-title":"J Clin Oncol"},{"key":"416_CR29","doi-asserted-by":"crossref","unstructured":"Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sol\u00e9 F, et al. Revised international prognostic scoring system (IPSS-R) for myelodysplastic syndromes. Blood [Internet]. 2012;2454\u201365. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22740453 .","DOI":"10.1182\/blood-2012-03-420489"},{"key":"416_CR30","doi-asserted-by":"crossref","unstructured":"Onida F, Kantarjian HM, Smith TL, Ball G, Keating MJ, Estey EH, Glassman AB, Albitar M, Kwari MI, Beran M. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients Prognostic factors and scoring systems in chronic myelomonocytic leukemia\u00a0: a retrospective analysis of 213 patients. Blood. 2002;99(3):840\u20139.","DOI":"10.1182\/blood.V99.3.840"},{"key":"416_CR31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1182\/blood-2002-01-0330","volume":"100","author":"U Germing","year":"2002","unstructured":"Germing U, Strupp C, Aivado M, Gattermann N. New prognostic parameters for chronic myelomonocytic leukemia? Blood. 2002;100:731\u20133.","journal-title":"Blood"},{"issue":"6","key":"416_CR32","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1080\/10428190701216386","volume":"48","author":"M Beran","year":"2007","unstructured":"Beran M, Wen S, Shen Y, Onida F, Jelinek J, Cortes J, et al. Prognostic factors and risk assessment in chronic myelomonocytic leukemia: validation study of the M.D. Anderson Prognostic Scoring System. Leuk Lymphoma. 2007;48(6):1150\u201360.","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"416_CR33","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ajh.23574","volume":"88","author":"SA Parikh","year":"2013","unstructured":"Parikh SA, Tefferi A. Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management. Am J Hematol. 2013;88(11):967\u201374.","journal-title":"Am J Hematol"},{"issue":"12","key":"416_CR34","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood-2012-06-440347","volume":"121","author":"R Itzykson","year":"2013","unstructured":"Itzykson R, Kosmider O, Renneville A, Morabito M, Preudhomme C, Berthon C, et al. Clonal architecture of chronic myelomonocytic leukemias. Blood. 2013;121(12):2186\u201398.","journal-title":"Blood"},{"issue":"7","key":"416_CR35","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/leu.2013.100","volume":"27","author":"R Itzykson","year":"2013","unstructured":"Itzykson R, Solary E. An evolutionary perspective on chronic myelomonocytic leukemia. Leukemia. 2013;27(7):1441\u201350. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23558522","journal-title":"Leukemia"},{"issue":"3","key":"416_CR36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3324\/haematol.2010.030957","volume":"96","author":"E Such","year":"2011","unstructured":"Such E, Cervera J, Costa D, Sol\u00e9 F, Vallesp\u00ed T, Lu\u00f1o E, et al. Cytogenetic risk stratification in chronic myelomonocytic leukemia. Haematologica. 2011;96(3):375\u201383.","journal-title":"Haematologica"},{"issue":"15","key":"416_CR37","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood-2012-08-452938","volume":"121","author":"E Such","year":"2013","unstructured":"Such E, Germing U, Malcovati L, Cervera J, Kuendgen A, Della Porta MG, et al. Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia. Blood. 2013;121(15):3005\u201315.","journal-title":"Blood"},{"issue":"7","key":"416_CR38","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/leu.2013.88","volume":"27","author":"MM Patnaik","year":"2013","unstructured":"Patnaik MM, Padron E, LaBorde RR, Lasho TL, Finke CM, Hanson CA, et al. Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes. Leukemia. 2013;27(7):1504\u201310. Available from: http:\/\/eutils.ncbi.nlm.nih.gov\/entrez\/eutils\/elink.fcgi?dbfrom=pubmed&id=23531518&retmode=ref&cmd=prlinks%5Cnpapers2:\/\/publication\/doi\/10.1038\/leu.2013.88","journal-title":"Leukemia"},{"issue":"19","key":"416_CR39","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1200\/JCO.2012.47.3314","volume":"31","author":"R Itzykson","year":"2013","unstructured":"Itzykson R, Kosmider O, Renneville A, Gelsi-Boyer V, Meggendorfer M, Morabito M, et al. Prognostic score including gene mutations in chronic myelomonocytic leukemia. J Clin Oncol. 2013;31(19):2428\u201336.","journal-title":"J Clin Oncol"},{"issue":"4","key":"416_CR40","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2141.2010.08381.x","volume":"151","author":"V Gelsi-Boyer","year":"2010","unstructured":"Gelsi-Boyer V, Trouplin V, Roquain J, Ad\u00e9la\u00efde J, Carbuccia N, Esterni B, et al. ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia. Br J Haematol. 2010;151(4):365\u201375.","journal-title":"Br J Haematol"},{"key":"416_CR41","doi-asserted-by":"crossref","unstructured":"Xavier Calvo, Meritxell Nomdedeu, Rodrigo Santacruz, N\u00faria Mart\u00ednez, Dolors Costa, Arturo Pereira, Natalia Estrada, Blanca Xicoy, Jordi Esteve, Benet Nomdedeu. Comparison of three prognostic scoring systems in a series of 146 cases of chronic myelomonocytic leukemia (CMML): MD Anderson Prognostic Score (MDAPS), CMML-Specific Prognostic Scoring System (CPSS) and mayo prognostic model. In: Blood. 2014. p. 4660.","DOI":"10.1016\/j.leukres.2015.05.017"},{"issue":"11","key":"416_CR42","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.leukres.2015.05.017","volume":"39","author":"X Calvo","year":"2015","unstructured":"Calvo X, Nomdedeu M, Santacruz R, Mart\u00ednez N, Costa D, Pereira A, et al. Comparison of three prognostic scoring systems in a series of 146 cases of chronic myelomonocytic leukemia (CMML): MD Anderson prognostic score (MDAPS), CMML-specific prognostic scoring system (CPSS) and Mayo prognostic model. A detailed review of prognos. Leuk Res. 2015;39(11):1146\u201353.","journal-title":"Leuk Res"},{"issue":"11","key":"416_CR43","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/leu.2014.125","volume":"28","author":"M Patnaik","year":"2014","unstructured":"\u2022 Patnaik M, Itzykson R, Lasho T, Kosmider O, Finke C, Hanson C, et al. ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients. Leukemia. 2014;28(11):2206\u201312. https:\/\/doi.org\/10.1038\/leu.2014.125 . This article illustrates the Molecular Mayo Model of prognostication in CMML, developed by an important cooperative study of the Mayo Clinic with GFM.","journal-title":"Leukemia"},{"issue":"12","key":"416_CR44","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/ajh.23846","volume":"89","author":"EA Wassie","year":"2014","unstructured":"\u2022 Wassie EA, Itzykson R, Lasho TL, Kosmider O, Finke CM, Hanson CA, et al. Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study. Am J Hematol. 2014;89(12):1111\u20135. The Mayo-French cytogenetic classification was the first to identify the negative prognostic significance of monosomal karyotype in CMML.","journal-title":"Am J Hematol"},{"issue":"2","key":"416_CR45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clml.2014.06.007","volume":"15","author":"A Alsahlawi","year":"2015","unstructured":"Alsahlawi A, Alkhateeb H, Patnaik M, Begna K, Elliott M, Hogan WJ, et al. Monosomal karyotype predicts adverse prognosis in patients diagnosed with chronic myelomonocytic leukemia: a single-institution experience. Clin Lymphoma Myeloma Leuk. 2015;15(2):39\u201341.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"7","key":"416_CR46","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1038\/bcj.2015.53","volume":"5","author":"E Padron","year":"2015","unstructured":"\u2022\u2022 Padron E, Garcia-Manero G, Patnaik MM, Itzykson R, Lasho T, Nazha A, et al. An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies. Blood Cancer J. 2015;5(7):e333. https:\/\/doi.org\/10.1038\/bcj.2015.53 . This study reports on the comparison between the most important prognostic models in a joint dataset from a very large series of patients from eight tertiary cancer centers in three different countries.","journal-title":"Blood Cancer J"},{"issue":"1","key":"416_CR47","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1038\/bcj.2014.90","volume":"4","author":"MM Patnaik","year":"2015","unstructured":"\u2022 Patnaik MM, Wassie EA, Padron E, Onida F, Itzykson R, Lasho TL, et al. Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome. Blood Cancer J. 2015;4(1):e270. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25555161 . This was the first study to investigate on prognostic factors in young patients (age <\u00a065\u00a0years) with CMML.","journal-title":"Blood Cancer J."},{"key":"416_CR48","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Elena C, Gall A, Such E, Meggendorfer M, Germing U, Rizzo E, et al. Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia. Blood. 2016;128(10):1408\u201317. The CPSS-mol is the first model to incorporate multiple genes mutations together with clinical characteristics to assess prognosis of CMML patients.","DOI":"10.1182\/blood-2016-05-714030"},{"key":"416_CR49","doi-asserted-by":"crossref","unstructured":"Francesco Onida, Simona Iacobelli, Guillermo Garcia-Manero, Mrinal M Patnaik, Rapha\u00ebl Itzykson, Terra L. Lasho, Aziz Nazha, Raajit K. Rampal, Matias Eugenio Sanchez, Elias J. Jabbour, Najla H Al Ali, Zachary Thompson, Simona Colla, Pierre Fenaux, Hagop M. Kantarjian, Eric Solary and Eric Padron. A new clinically-based subclassification proposal in cmml with significant prognostic implications to overcome the MDS\/MPN categorizing dilemma. Vol. 128, Blood. 2016.","DOI":"10.1182\/blood.V128.22.4320.4320"},{"key":"416_CR50","doi-asserted-by":"crossref","unstructured":"C. Rautenberg, E. Schuler, K. Nachtkamp, T. Schroeder, S. Blum, C. Aul, R. Haas, U. Germing. Validation of a new clinically based classification system for stratification of prognosis in patients with CMML. Vol. 55, Leukemia Research. 2017.","DOI":"10.1016\/S0145-2126(17)30372-7"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-017-0416-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-017-0416-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-017-0416-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T23:56:02Z","timestamp":1719532562000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-017-0416-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["416"],"URL":"https:\/\/doi.org\/10.1007\/s11899-017-0416-8","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,24]]}}}